Novartis AG Statistics

Total Valuation

Novartis AG has a market cap or net worth of EUR 260.55 billion. The enterprise value is 281.93 billion.

Market Cap	260.55B
Enterprise Value	281.93B

Important Dates

The next confirmed earnings date is Tuesday, April 28, 2026.

Earnings Date	Apr 28, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	1.91B
Shares Outstanding	n/a
Shares Change (YoY)	-3.93%
Shares Change (QoQ)	-0.57%
Owned by Insiders (%)	0.11%
Owned by Institutions (%)	36.99%
Float	1.82B

Valuation Ratios

The trailing PE ratio is 21.88 and the forward PE ratio is 17.85.

PE Ratio	21.88
Forward PE	17.85
PS Ratio	5.40
PB Ratio	6.57
P/TBV Ratio	n/a
P/FCF Ratio	17.39
P/OCF Ratio	15.98
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.52, with an EV/FCF ratio of 18.81.

EV / Earnings	23.67
EV / Sales	5.66
EV / EBITDA	13.52
EV / EBIT	16.90
EV / FCF	18.81

Financial Position

The company has a current ratio of 1.12, with a Debt / Equity ratio of 0.76.

Current Ratio	1.12
Quick Ratio	0.82
Debt / Equity	0.76
Debt / EBITDA	1.49
Debt / FCF	2.02
Interest Coverage	16.61

Financial Efficiency

Return on equity (ROE) is 30.81% and return on invested capital (ROIC) is 23.60%.

Return on Equity (ROE)	30.81%
Return on Assets (ROA)	11.14%
Return on Invested Capital (ROIC)	23.60%
Return on Capital Employed (ROCE)	22.71%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	641,307
Profits Per Employee	158,239
Employee Count	75,267
Asset Turnover	0.53
Inventory Turnover	2.27

Taxes

In the past 12 months, Novartis AG has paid 2.03 billion in taxes.

Income Tax	2.03B
Effective Tax Rate	14.59%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	129.39
200-Day Moving Average	112.57
Relative Strength Index (RSI)	49.05
Average Volume (20 Days)	10

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novartis AG had revenue of EUR 48.27 billion and earned 11.91 billion in profits. Earnings per share was 6.09.

Revenue	48.27B
Gross Profit	36.67B
Operating Income	16.19B
Pretax Income	13.93B
Net Income	11.91B
EBITDA	19.99B
EBIT	16.19B
Earnings Per Share (EPS)	6.09

Full Income Statement

Balance Sheet

The company has 9.82 billion in cash and 30.20 billion in debt, giving a net cash position of -20.38 billion.

Cash & Cash Equivalents	9.82B
Total Debt	30.20B
Net Cash	-20.38B
Net Cash Per Share	n/a
Equity (Book Value)	39.65B
Book Value Per Share	20.59
Working Capital	2.71B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 16.30 billion and capital expenditures -1.32 billion, giving a free cash flow of 14.99 billion.

Operating Cash Flow	16.30B
Capital Expenditures	-1.32B
Free Cash Flow	14.99B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 75.97%, with operating and profit margins of 33.53% and 24.67%.

Gross Margin	75.97%
Operating Margin	33.53%
Pretax Margin	28.85%
Profit Margin	24.67%
EBITDA Margin	41.42%
EBIT Margin	33.53%
FCF Margin	31.05%

Dividends & Yields

Novartis AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	3.93%
Shareholder Yield	3.93%
Earnings Yield	4.57%
FCF Yield	5.75%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novartis AG has an Altman Z-Score of 3.81 and a Piotroski F-Score of 7.

Altman Z-Score	3.81
Piotroski F-Score	7